NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NeuroPace Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.77+0.53 (+4.33%)
Close on Oct 19, 2026
- Market cap
- $435.51M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Dividends
NeuroPace has not reported a dividend
No dividend per share appears in NeuroPace's annual filings since fiscal 2019.